Mylan Asks Fed. Circ. To Mull Hatch-Waxman Jurisdiction
Mylan Pharmaceuticals Inc. has asked the Federal Circuit to allow the company to appeal a Delaware federal court's decision in a Hatch-Waxman suit over its generic versions of AstraZeneca AB drugs,...To view the full article, register now.
Already a subscriber? Click here to view full article